Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Action plans and coping strategies in elderly COPD patients influence the result of pulmonary rehabilitation: an observational study.

Russo P, Prinzi G, Kisialiou A, Cardaci V, Stirpe E, Conti V, Fini M, Bonassi S.

Eur J Phys Rehabil Med. 2017 Apr 14. doi: 10.23736/S1973-9087.17.04501-4. [Epub ahead of print]

2.

Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.

Lamonaca P, Prinzi G, Kisialiou A, Cardaci V, Fini M, Russo P.

Mar Drugs. 2017 Mar 20;15(3). pii: E81. doi: 10.3390/md15030081. Review.

3.

A CGH array procedure to detect PAX6 gene structural defects.

Franzoni A, Russo PD, Baldan F, D'Elia AV, Puppin C, Penco S, Damante G.

Mol Cell Probes. 2017 Apr;32:65-68. doi: 10.1016/j.mcp.2016.12.001. Epub 2016 Dec 2.

PMID:
27919838
4.

New Drugs from Marine Organisms in Alzheimer's Disease.

Russo P, Kisialiou A, Lamonaca P, Moroni R, Prinzi G, Fini M.

Mar Drugs. 2015 Dec 25;14(1):5. doi: 10.3390/md14010005. Review.

5.

Deep sea as a source of novel-anticancer drugs: update on discovery and preclinical/clinical evaluation in a systems medicine perspective.

Russo P, Del Bufalo A, Fini M.

EXCLI J. 2015 Feb 10;14:228-36. doi: 10.17179/excli2015-632. eCollection 2015. Review.

6.

Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.

Russo P, Kisialiou A, Moroni R, Prinzi G, Fini M.

Curr Drug Targets. 2015 Oct 1. [Epub ahead of print]

PMID:
26424395
7.

Novel therapeutic strategy in the management of COPD: a systems medicine approach.

Lococo F, Cesario A, Del Bufalo A, Ciarrocchi A, Prinzi G, Mina M, Bonassi S, Russo P.

Curr Med Chem. 2015;22(32):3655-75. Review.

PMID:
26337103
8.

DNA damage in non-communicable diseases: A clinical and epidemiological perspective.

Milic M, Frustaci A, Del Bufalo A, Sánchez-Alarcón J, Valencia-Quintana R, Russo P, Bonassi S.

Mutat Res. 2015 Jun;776:118-27. doi: 10.1016/j.mrfmmm.2014.11.009. Epub 2014 Dec 10. Review.

PMID:
26255943
9.

A systems medicine clinical platform for understanding and managing non- communicable diseases.

Cesario A, Auffray C, Agusti A, Apolone G, Balling R, Barbanti P, Bellia A, Boccia S, Bousquet J, Cardaci V, Cazzola M, Dall'Armi V, Daraselia N, Ros LD, Bufalo AD, Ducci G, Ferri L, Fini M, Fossati C, Gensini G, Granone PM, Kinross J, Lauro D, Cascio GL, Lococo F, Lococo A, Maier D, Marcus F, Margaritora S, Marra C, Minati G, Neri M, Pasqua F, Pison C, Pristipino C, Roca J, Rosano G, Rossini PM, Russo P, Salinaro G, Shenhar S, Soreq H, Sterk PJ, Stocchi F, Torti M, Volterrani M, Wouters EF, Frustaci A, Bonassi S.

Curr Pharm Des. 2014;20(38):5945-56. Review.

PMID:
24641232
10.

P4 medicine needs P4 education.

Cesario A, Auffray C, Russo P, Hood L.

Curr Pharm Des. 2014;20(38):6071-2. Review.

PMID:
24641231
11.

Alpha9 alpha10 nicotinic acetylcholine receptors as target for the treatment of chronic pain.

Del Bufalo A, Cesario A, Salinaro G, Fini M, Russo P.

Curr Pharm Des. 2014;20(38):6042-7. Review.

PMID:
24641230
12.

Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.

Russo P, Del Bufalo A, Frustaci A, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):6014-21. Review.

PMID:
24641224
13.

Disease control and active and healthy ageing: new paradigms of therapeutic strategy.

Russo P, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):5919-20. No abstract available.

PMID:
24641221
14.

Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.

Russo PD, Damante G, Pasca S, Turello M, Barillari G.

Clin Appl Thromb Hemost. 2015 May;21(4):373-7. doi: 10.1177/1076029614522544. Epub 2014 Feb 25.

PMID:
24569626
15.

EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation.

Antonicelli A, Cafarotti S, Indini A, Galli A, Russo A, Cesario A, Lococo FM, Russo P, Mainini AF, Bonifati LG, Nosotti M, Santambrogio L, Margaritora S, Granone PM, Dutly AE.

Int J Med Sci. 2013;10(3):320-30. doi: 10.7150/ijms.4609. Epub 2013 Feb 11. Review.

16.

Nicotinic receptor and tobacco-related cancer.

Russo P, Cardinale A, Margaritora S, Cesario A.

Life Sci. 2012 Nov 27;91(21-22):1087-92. doi: 10.1016/j.lfs.2012.05.003. Epub 2012 Jun 15. Review.

PMID:
22705232
17.

New anticancer drugs from marine cyanobacteria.

Russo P, Cesario A.

Curr Drug Targets. 2012 Jul;13(8):1048-53. Review.

PMID:
22594472
18.

Presentation to the special issue: "α7-nicotinic receptor (α7-nAChR): one target different diseases".

Russo P, Cesario A, Cardinale A.

Curr Drug Targets. 2012 May;13(5):573. No abstract available.

PMID:
22564210
19.

Concluding notes of special issue "α-7 nicotinic receptor (α7-nAChR): one target different diseases".

Russo P, Cesario A, Fini M.

Curr Drug Targets. 2012 May;13(5):726-7. No abstract available.

PMID:
22300041
20.

A new "era" for the α7-nAChR.

Russo P, Cardinale A, Shuller H.

Curr Drug Targets. 2012 May;13(5):721-5.

PMID:
22300040

Supplemental Content

Loading ...
Support Center